We are live on ! Find out more
EVGN icon

Evogene
EVGN

19 hedge funds and large institutions have $56.7M invested in Evogene in 2015 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 8 increasing their positions, 0 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 2

8% more capital invested

Capital invested by funds: $52.6M → $56.7M (+$4.11M)

6% more funds holding

Funds holding: 18 → 19 (+1)

2.63% more ownership

Funds ownership: 25.13% → 27.76% (+2.6%)

Holders
19
Holders Change
+1
Holders Change %
+5.56%
% of All Funds
0.5%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
8
Reduced
–
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
+$2.58M
2
Bank of America
Bank of America
North Carolina
+$866K
3
Goldman Sachs
Goldman Sachs
New York
+$669K
4
Wellington Management Group
Wellington Management Group
Massachusetts
+$346K
5
Vanguard Group
Vanguard Group
Pennsylvania
+$245K

Top Sellers

Rank Fund Capital Flow
1
HSBC Holdings
HSBC Holdings
United Kingdom
-$124K
2
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale
Germany
-$31K

EVGN Hedge Fund Activity: Q4 2015 in Review

19 of the 3,824 institutional investors tracked by Wall St. Rank reported a position in Evogene (EVGN) for Q4 2015, worth a combined $56.7M — up 7.8% from $52.6M a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new EVGN positions and 2 closed out — a net gain of 1 holder — while 8 added to existing stakes and 0 trimmed.

The largest buyer was UBS Group, adding an estimated $2.58M. The largest seller was HSBC Holdings, exiting entirely with an estimated $124K sold.

  • 19 institutional investors held Evogene (EVGN) as of Q4 2015, up from 18 in Q3 2015.
  • Funds reported $56.7M of Evogene stock for Q4 2015, up 7.8% quarter-over-quarter.
  • 3 funds opened new Evogene positions in Q4 2015 and 2 closed out, a net change of +1 holder.
  • The largest Evogene buyer in Q4 2015 was UBS Group, an estimated $2.58M added.
  • The largest Evogene seller in Q4 2015 was HSBC Holdings, an estimated $124K sold.

Based on aggregated 13F filings for Q4 2015.